Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
maria.fernandez-suarez@pharm.ox.ac.uk

Telephone
+44 (0)1865 271874

Research groups

Platt Laboratory | Lysosomal and Sphingolipid Disorders

Maria Fernandez-Suarez

Newton International Fellow

Recent publications

GPNMB and glycosphingolipid measurements in cerebrospinal fluid and plasma from Parkinson’s disease patients

Fernandez-Suarez ME. et al, (2026)

Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.

Wallom K-L. et al, (2022), Glycoconj J, 39, 39 - 53

Selective estrogen receptor modulators (SERMs) affect cholesterol homeostasis through the master regulators SREBP and LXR.

Fernández-Suárez ME. et al, (2021), Biomed Pharmacother, 141

Role of cholesterol metabolism in the anticancer pharmacology of selective estrogen receptor modulators.

Gómez-Coronado D. et al, (2021), Semin Cancer Biol, 73, 101 - 115

Unbiased yeast screens identify cellular pathways affected in Niemann-Pick disease type C.

Colaco A. et al, (2020), Life Sci Alliance, 3

More publications